Cargando…
Using cost-effectiveness analysis to support policy change: varenicline and nicotine replacement therapy for smoking cessation in Jordan
BACKGROUND: Smoking cessation pharmacotherapies (SCPs) have been established as cost-effective for the treatment of tobacco use disorder across a variety of settings. In Jordan, a resource-constrained country where smoking rates rank at one of the highest globally, the cost-effectiveness of SCPs has...
Autores principales: | Madae’en, Saba, Obeidat, Nour, Adeinat, Mohammad |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7590594/ https://www.ncbi.nlm.nih.gov/pubmed/33117544 http://dx.doi.org/10.1186/s40545-020-00270-y |
Ejemplares similares
-
Varenicline for Smoking Cessation: Nausea Severity and Variation in Nicotinic Receptor Genes
por: Swan, Gary E., et al.
Publicado: (2011) -
Combination of varenicline and nicotine patch for smoking cessation: A case report
por: Young, Kelly M., et al.
Publicado: (2019) -
Combination of behavioral therapy and varenicline for smoking cessation: Time to beat nicotine
por: Agarwal, Avnica, et al.
Publicado: (2022) -
Prospective cohort study of the effectiveness of varenicline versus nicotine replacement therapy for smoking cessation in the “real world”
por: Kotz, Daniel, et al.
Publicado: (2014) -
Clinical Effectiveness and Cost-Effectiveness of Oral-Health Promotion in Dental Caries Prevention among Children: Systematic Review and Meta-Analysis
por: Fraihat, Nadine, et al.
Publicado: (2019)